Literature DB >> 24758718

Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes.

Lina T Al Kury1, Oleg I Voitychuk, Keun-Hang Susan Yang, Faisal T Thayyullathil, Petro Doroshenko, Ali M Ramez, Yaroslav M Shuba, Sehamuddin Galadari, Frank Christopher Howarth, Murat Oz.   

Abstract

BACKGROUND AND
PURPOSE: The endocannabinoid anandamide (N-arachidonoyl ethanolamide; AEA) exerts negative inotropic and antiarrhythmic effects in ventricular myocytes. EXPERIMENTAL APPROACH: Whole-cell patch-clamp technique and radioligand-binding methods were used to analyse the effects of anandamide in rat ventricular myocytes. KEY
RESULTS: In the presence of 1-10 μM AEA, suppression of both Na(+) and L-type Ca(2+) channels was observed. Inhibition of Na(+) channels was voltage and Pertussis toxin (PTX) - independent. Radioligand-binding studies indicated that specific binding of [(3) H] batrachotoxin (BTX) to ventricular muscle membranes was also inhibited significantly by 10 μM metAEA, a non-metabolized AEA analogue, with a marked decrease in Bmax values but no change in Kd . Further studies on L-type Ca(2+) channels indicated that AEA potently inhibited these channels (IC50 0.1 μM) in a voltage- and PTX-independent manner. AEA inhibited maximal amplitudes without affecting the kinetics of Ba(2+) currents. MetAEA also inhibited Na(+) and L-type Ca(2+) currents. Radioligand studies indicated that specific binding of [(3) H]isradipine, was inhibited significantly by metAEA. (10 μM), changing Bmax but not Kd . CONCLUSION AND IMPLICATIONS: Results indicate that AEA inhibited the function of voltage-dependent Na(+) and L-type Ca(2+) channels in rat ventricular myocytes, independent of CB1 and CB2 receptor activation.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  L-type Ca2+ channel; anandamide; Na+ channel; endocannabinoid; ventricular myocyte

Mesh:

Substances:

Year:  2014        PMID: 24758718      PMCID: PMC4105935          DOI: 10.1111/bph.12734

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  64 in total

1.  G-protein alpha subunit isoforms couple differentially to receptors that mediate presynaptic inhibition at rat hippocampal synapses.

Authors:  Alex J Straiker; Catherine R Borden; Jane M Sullivan
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

2.  Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism.

Authors:  A V Krylatov; R V Uzhachenko; L N Maslov; N A Bernatskaya; A Makriyannis; R Mechoulam; R G Pertwee; O M Sal'nikova; J B Stefano; YuB Lishmanov
Journal:  Bull Exp Biol Med       Date:  2002-02       Impact factor: 0.804

3.  Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart.

Authors:  Jean-François Bouchard; Philippe Lépicier; Daniel Lamontagne
Journal:  Life Sci       Date:  2003-03-07       Impact factor: 5.037

4.  Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain.

Authors:  R A Nicholson; C Liao; J Zheng; L S David; L Coyne; A C Errington; G Singh; G Lees
Journal:  Brain Res       Date:  2003-07-18       Impact factor: 3.252

5.  Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia?

Authors:  Christian Berger; Patricia C Schmid; Wolf-Ruediger Schabitz; Margit Wolf; Stefan Schwab; Harald H O Schmid
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

6.  Does QT widening in the Langendorff-perfused rat heart represent the effect of repolarization delay or conduction slowing?

Authors:  András Farkas; Michael J Curtis
Journal:  J Cardiovasc Pharmacol       Date:  2003-11       Impact factor: 3.105

Review 7.  Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function.

Authors:  H H O Schmid; E V Berdyshev
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Feb-Mar       Impact factor: 4.006

8.  Effects of hyperosmotic shrinking on ventricular myocyte shortening and intracellular Ca(2+) in streptozotocin-induced diabetic rats.

Authors:  F C Howarth; M A Qureshi; E White
Journal:  Pflugers Arch       Date:  2002-04-04       Impact factor: 3.657

Review 9.  Dual modulation of CNS voltage-gated calcium channels by cannabinoids: Focus on CB1 receptor-independent effects.

Authors:  Natalia Lozovaya; Rogier Min; Vera Tsintsadze; Nail Burnashev
Journal:  Cell Calcium       Date:  2009-08-13       Impact factor: 6.817

10.  Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle.

Authors:  Andreas Bonz; Martin Laser; Sina Küllmer; Silke Kniesch; Jörg Babin-Ebell; Verena Popp; Georg Ertl; Jens Andreas Wagner
Journal:  J Cardiovasc Pharmacol       Date:  2003-04       Impact factor: 3.105

View more
  14 in total

1.  Marijuana Induced Type I Brugada Pattern: A Case Report.

Authors:  Pramod Theetha Kariyanna; Apoorva Jayarangaiah; Sudhanva Hegde; Jonathan D Marmur; Perry Wengrofsky; Mena Yacoub; Michael Post; Samy I McFarlane
Journal:  Am J Med Case Rep       Date:  2018-08-07

2.  The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo.

Authors:  Monte S Willis; Amro Ilaiwy; Megan D Montgomery; Paul C Simpson; Brian C Jensen
Journal:  Metabolomics       Date:  2016-09-15       Impact factor: 4.290

Review 3.  The endocannabinoid system in cardiovascular function: novel insights and clinical implications.

Authors:  Salvador Sierra; Natasha Luquin; Judith Navarro-Otano
Journal:  Clin Auton Res       Date:  2017-12-08       Impact factor: 4.435

4.  Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose.

Authors:  Milana Zaurova; Robert S Hoffman; David Vlahov; Alex F Manini
Journal:  J Med Toxicol       Date:  2016-06-02

5.  Direct activation of Ca2+ and voltage-gated potassium channels of large conductance by anandamide in endothelial cells does not support the presence of endothelial atypical cannabinoid receptor.

Authors:  Alexander I Bondarenko; Olga Panasiuk; Iryna Okhai; Fabrizio Montecucco; Karim J Brandt; Francois Mach
Journal:  Eur J Pharmacol       Date:  2017-03-19       Impact factor: 4.432

Review 6.  Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain.

Authors:  Adriana Della Pietra; Juha Savinainen; Rashid Giniatullin
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

Review 7.  Advances in the Physiology of GPR55 in the Central Nervous System.

Authors:  Bruno A Marichal-Cancino; Alfonso Fajardo-Valdez; Alejandra E Ruiz-Contreras; Monica Mendez-Díaz; Oscar Prospero-García
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

8.  A Unique Case of Cardiac Arrest following K2 Abuse.

Authors:  Saif Ibrahim; Farah Al-Saffar; Thomas Wannenburg
Journal:  Case Rep Cardiol       Date:  2014-05-25

9.  Synthetic Marijuana Induced Acute Nonischemic Left Ventricular Dysfunction.

Authors:  Moustafa Elsheshtawy; Priatharsini Sriganesh; Vasudev Virparia; Falgun Patel; Ashok Khanna
Journal:  Case Rep Cardiol       Date:  2016-03-28

10.  Potassium channels as molecular targets of endocannabinoids.

Authors:  Yu-Fung Lin
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.